R. J. Mayer

发表

Production and characterization of a polyclonal antibody to the c‐erbB‐3 protein: Examination of c‐erbB‐3 protein expression in adenocarcinomas

I. Ellis, I. Ellis, G. Plowman, 1992, The Journal of pathology.

Evaluation of Reconstituted Sendai Virus Envelopes as Intra‐articular Drug Vectors: Effects on Normal and Experimentally Arthritic Rabbit Knee Joints

E. Billett, R. Mayer, I. Hunneyball, 1988, The Journal of pharmacy and pharmacology.

Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in U.S. GI Intergroup RTOG 98-11 Phase III Trial

Charles R. Thomas, J. Ajani, C. Willett, 2010 .

αB crystallin expression in nonlenticular tissues and selective presence in ubiquitinated inclusion bodies in human disease

R. Mayer, I. Pike, H. Mcdermott, 1992, The Journal of pathology.

Recombinant Human Gamma Interferon Administered by Continuous Intravenous Infusion in Acute Myelogenous Leukemia and Myelodysplastic Syndromes

J. Griffin, D. Kufe, R. Mayer, 1993, American journal of clinical oncology.

Acute renal failure associated with neoplastic disease and its treatment.

R. Mayer, M. Garnick, R. J. Mayer, 1978, Seminars in oncology.

Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.

R. Mayer, C. Schiffer, J. Moore, 1994, The New England journal of medicine.

B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation.

S. Korsmeyer, S. Sallan, R. Mayer, 1984, The Journal of clinical investigation.

Prognostic value of lymphocyte surface markers in acute myeloid leukemia.

J. Griffin, R. Mayer, D. Arthur, 1991, Blood.

Doxorubicin in pregnancy: possible transplacental passage.

R. Mayer, M. Israel, M. Garnick, 1983, Cancer treatment reports.

Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered.

C. Bloomfield, J. Byrd, M. Qumsiyeh, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

C. Bloomfield, J. Byrd, S. Patil, 1998, Cancer research.

Use of surface marker analysis to predict outcome of adult acute myeloblastic leukemia.

C. Bloomfield, C. Schiffer, J. Griffin, 1986, Blood.

Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study.

C. Bloomfield, K. Mrózek, S. Bigner, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

C. Bloomfield, J. Byrd, M. Qumsiyeh, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Carcinoma of the anal canal.

C. Compton, D. Ryan, R. Mayer, 2000, The New England journal of medicine.

Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.

C. Bloomfield, C. Schiffer, S. George, 1994, Blood.

The unique aspects of acute promyelocytic leukemia.

R. Mayer, R. Stone, R. J. Mayer, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

R. Mayer, R. Stone, E. Rubin, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of psychosocial adaptation of advanced stage Hodgkin's disease and acute leukemia survivors. Cancer and Leukemia Group B.

J. Holland, C. Schiffer, D. Cella, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

The use of serologic tumor markers in gastrointestinal malignancies.

R. Mayer, M. Posner, M. Posner, 1994, Hematology/oncology clinics of North America.

Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.

M. Goldberg, D. Rosenthal, R. Mayer, 1988, Blood.

Morphologic and cytochemical characteristics of acute promyelocytic leukemia

C. Bloomfield, C. Schiffer, J. Griffin, 1989, American journal of hematology.

Long-term update of U.S. GI Intergroup RTOG 98-11 phase III trial for anal carcinoma: Comparison of concurrent chemoradiation with 5FU-mitomycin versus 5FU-cisplatin for disease-free and overall survival.

A. Benson, J. Ajani, C. Willett, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.